OTHER GROUP COMPANIES
market

FDC gets USFDA approval for Ofloxacin Otic Solution, 0.3%

The Company is mainly engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

January 24, 2022 9:16 IST | India Infoline News Service
FDC Limited has announced to the exchanges regarding receipt of ANDA approval for Ofloxacin Otic Solution, 0.3%.

In a regulatory filing, the company said that it has been granted ANDA approval by United States Food and Drug Administration (U.S. FDA), for Ofloxacin Otic Solution, 0.3%.

The Company is mainly engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

On Monday morning trade, FDC stock was trading at Rs287 per piece higher by 0.65% on Sensex.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity